• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Prime Medicine Inc (NQ: PRME )

    5.480 -0.130 (-2.32%)
    Streaming Delayed Price Updated: 10:36 AM EDT, Jul 29, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Prime Medicine Inc

    < Previous 1 2 3 Next >
    Prime Medicine to Present at Virtual Investor Conferences in May
    From Prime Medicine, Inc.
    Via GlobeNewswire
    Prime Medicine to Present New Preclinical Data Highlighting Broad Potential of Prime Editing Technology at ASGCT 26th Annual Meeting
    From Prime Medicine, Inc.
    Via GlobeNewswire
    Prime Medicine Reports First Quarter 2023 Financial Results and Provides Business Updates
    From Prime Medicine, Inc.
    Via GlobeNewswire
    Prime Medicine to Present at Guggenheim Healthcare Talks – Genomic Medicines and Rare Disease Days
    From Prime Medicine, Inc.
    Via GlobeNewswire
    Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2023
    Via Benzinga
    Prime Medicine Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
    From Prime Medicine, Inc.
    Via GlobeNewswire
    Prime Medicine to Present at Cowen 43rd Annual Health Care Conference
    From Prime Medicine, Inc.
    Via GlobeNewswire
    10 Short Squeeze Candidates: Getty Images, Genius Brands, MicroStrategy And More
    Potential short squeeze plays gained steam in 2021 and continued through 2022, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the common traits... 
    Via Benzinga
    Prime Medicine Announces Recent Progress and Highlights 2023 Strategic Priorities
    From Prime Medicine, Inc.
    Via GlobeNewswire
    Prime Medicine to Present at 41st Annual J.P. Morgan Healthcare Conference
    From Prime Medicine, Inc.
    Via GlobeNewswire
    Why Iovance Biotherapeutics Shares Are Trading Higher By Around 19%? Here Are 40 Stocks Moving In Monday's Mid-Day Session
    Gainers Winc, Inc. (NYSE: WBEV) rose 88.5% to $0.3901 after dropping over 23% on Friday. Winc, last month, posted a Q3 loss of $0.33 per share. 
    Via Benzinga
    VF Corp, Verve Therapeutics And Some Other Big Stocks Moving Lower On Monday
    U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Monday. Here are some big stocks recording losses in today’s session. 
    Via Benzinga
    Why Taboola Shares Are Trading Higher By Around 53%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
    Gainers Taboola.com Ltd. (NASDAQ: TBLA) shares gained 52.5% to $2.8050 after the company announced it entered into a 30-year exclusive commercial agreement with Yahoo. 
    Via Benzinga
    CinCor Pharma, Anavex Life Sciences And Some Other Big Stocks Moving Lower On Monday
    U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Monday. Here are some big stocks recording losses in today’s session. 
    Via Benzinga
    Opening Day: Snail Slides In Public Debut, Then Announces Share Buyback
    Shares of digital gaming company Snail opened for trading more than 50% lower at $2.20 after pricing shares of its Class A common stock at $5, then followed its first day on the market with a buyback... 
    Via Talk Markets
    $41 Million Bet On This Biotechnology Stock? 3 Stocks Insiders Are Buying
    Although US stocks closed mostly lower on Wednesday, there were a few notable insider trades. 
    Via Benzinga
    Prime Medicine Announces Closing of Upsized Initial Public Offering
    From Prime Medicine, Inc.
    Via GlobeNewswire
    Prime Medicine Stock Down 18.98% Since IPO
    Prime Medicine (NASDAQ:PRME) opened up its shares for public trading for the first time since it filed for IPO in September 2022. The company agreed to initially offer 10.29 million shares to the... 
    Via Benzinga
    What Is Going on With Silo Pharma (SILO) Stock Today?
    Silo Pharma (SILO) stock is falling on Thursday despite the company releasing positive data from a pre-clinical Alzheimer's study. 
    Via InvestorPlace
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.